Medish Healthcare
Search

Cart

More Details

Mintop Forte 2% Solution is a topical treatment primarily used for hair regrowth and reducing hair thinning in cases of androgenetic alopecia (male or female pattern baldness). Its active ingredient, Minoxidil, stimulates hair follicles, increases blood flow to the scalp, and promotes hair growth.

---

Key Information

Active Ingredient

Minoxidil (2%): A vasodilator that helps improve hair follicle function and stimulates the hair growth cycle.

---

How It Works

Enhances blood flow to the scalp, which provides nutrients to hair follicles.

Prolongs the anagen (growth) phase of the hair cycle.

---

How to Use

1. Clean and dry your scalp: Ensure your scalp is completely dry before application.

2. Apply the solution: Using the applicator provided, apply 1 ml of Mintop Forte 2% Solution to the affected scalp area twice daily (morning and evening).

3. Do not wash off: Allow the solution to absorb naturally. Avoid shampooing your hair for at least 4 hours after application.

4. Wash your hands: Clean your hands thoroughly after applying the solution.

---

Precautions

Consistency is key: It may take 3-4 months of consistent use to see visible results.

Avoid excess use: Using more than recommended will not accelerate results and may increase side effects.

Not for sudden hair loss: This product is specifically for hereditary hair thinning and should not be used for other types of hair loss.

Consult a doctor: If you're pregnant, breastfeeding, or have pre-existing scalp conditions, seek medical advice before use.

---

Common Side Effects

Scalp irritation (itching, redness, dryness)

Unwanted facial hair growth (if the solution comes into contact with other areas)

Temporary hair shedding during the initial weeks of use

---

Who Should Avoid It?

People under 18 or over 65 years old

Those with a history of allergies to Minoxidil

Individuals with heart-related issues (consult a doctor before use)

---

Would you like details about where to purchase it, user reviews, or alternatives?